Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces Completion of Its 20th Pre-Clinical Study

CANNANNEW REPORT

March 17, 2021 07:15 AM Eastern Daylight Time TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company… Read More…..

Excerpt only …
READ MORE BELOW
Source : Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces Completion of Its 20th Pre-Clinical Study

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.